648 related articles for article (PubMed ID: 24244039)
21. Cholecystokinin octapeptide significantly suppresses collagen-induced arthritis in mice by inhibiting Th17 polarization primed by dendritic cells.
Li Q; Han D; Cong B; Shan B; Zhang J; Chen H; Ma C; Liyanage SS
Cell Immunol; 2011; 272(1):53-60. PubMed ID: 22004797
[TBL] [Abstract][Full Text] [Related]
22. Blockade of NKG2D ameliorates disease in mice with collagen-induced arthritis: a potential pathogenic role in chronic inflammatory arthritis.
Andersson AK; Sumariwalla PF; McCann FE; Amjadi P; Chang C; McNamee K; Tornehave D; Haase C; Agersø H; Stennicke VW; Ahern D; Ursø B; Trowsdale J; Feldmann M; Brennan FM
Arthritis Rheum; 2011 Sep; 63(9):2617-29. PubMed ID: 21618462
[TBL] [Abstract][Full Text] [Related]
23. α2β1 integrin regulates Th17 cell activity and its neutralization decreases the severity of collagen-induced arthritis.
El Azreq MA; Boisvert M; Cesaro A; Pagé N; Loubaki L; Allaeys I; Chakir J; Poubelle PE; Tessier PA; Aoudjit F
J Immunol; 2013 Dec; 191(12):5941-50. PubMed ID: 24244022
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of concurrent administration of cilostazol and methotrexate in rheumatoid arthritis: pharmacologic and clinical significance.
Kim HY; Lee SW; Park SY; Baek SH; Lee CW; Hong KW; Kim CD
Life Sci; 2012 Sep; 91(7-8):250-7. PubMed ID: 22820172
[TBL] [Abstract][Full Text] [Related]
25. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
[TBL] [Abstract][Full Text] [Related]
26. PI3Kgamma regulates cartilage damage in chronic inflammatory arthritis.
Hayer S; Pundt N; Peters MA; Wunrau C; Kühnel I; Neugebauer K; Strietholt S; Zwerina J; Korb A; Penninger J; Joosten LA; Gay S; Rückle T; Schett G; Pap T
FASEB J; 2009 Dec; 23(12):4288-98. PubMed ID: 19734303
[TBL] [Abstract][Full Text] [Related]
27. Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression.
Nishida K; Komiyama T; Miyazawa S; Shen ZN; Furumatsu T; Doi H; Yoshida A; Yamana J; Yamamura M; Ninomiya Y; Inoue H; Asahara H
Arthritis Rheum; 2004 Oct; 50(10):3365-76. PubMed ID: 15476220
[TBL] [Abstract][Full Text] [Related]
28. Anti‑inflammatory effects of oxymatrine on rheumatoid arthritis in rats via regulating the imbalance between Treg and Th17 cells.
Ma A; Yang Y; Wang Q; Wang Y; Wen J; Zhang Y
Mol Med Rep; 2017 Jun; 15(6):3615-3622. PubMed ID: 28440447
[TBL] [Abstract][Full Text] [Related]
29. Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents.
Lin HS; Hu CY; Chan HY; Liew YY; Huang HP; Lepescheux L; Bastianelli E; Baron R; Rawadi G; Clément-Lacroix P
Br J Pharmacol; 2007 Apr; 150(7):862-72. PubMed ID: 17325656
[TBL] [Abstract][Full Text] [Related]
30. Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process.
Smith RJ; Sly LM
J Pharmacol Exp Ther; 1996 Jun; 277(3):1801-13. PubMed ID: 8667252
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model.
Zhang Y; Ren G; Guo M; Ye X; Zhao J; Xu L; Qi J; Kan F; Liu M; Li D
Int Immunopharmacol; 2013 Feb; 15(2):199-205. PubMed ID: 23280345
[TBL] [Abstract][Full Text] [Related]
32. Oleuropein aglycone, an olive oil compound, ameliorates development of arthritis caused by injection of collagen type II in mice.
Impellizzeri D; Esposito E; Mazzon E; Paterniti I; Di Paola R; Morittu VM; Procopio A; Britti D; Cuzzocrea S
J Pharmacol Exp Ther; 2011 Dec; 339(3):859-69. PubMed ID: 21880869
[TBL] [Abstract][Full Text] [Related]
33. Betahistine attenuates murine collagen-induced arthritis by suppressing both inflammatory and Th17 cell responses.
Tang KT; Chao YH; Chen DY; Lim YP; Chen YM; Li YR; Yang DH; Lin CC
Int Immunopharmacol; 2016 Oct; 39():236-245. PubMed ID: 27494687
[TBL] [Abstract][Full Text] [Related]
34. Suppression of hyaluronan synthesis alleviates inflammatory responses in murine arthritis and in human rheumatoid synovial fibroblasts.
Yoshioka Y; Kozawa E; Urakawa H; Arai E; Futamura N; Zhuo L; Kimata K; Ishiguro N; Nishida Y
Arthritis Rheum; 2013 May; 65(5):1160-70. PubMed ID: 23335273
[TBL] [Abstract][Full Text] [Related]
35. IL-17 increases cadherin-11 expression in a model of autoimmune experimental arthritis and in rheumatoid arthritis.
Park YE; Woo YJ; Park SH; Moon YM; Oh HJ; Kim JI; Jin HS; Baek SH; Kim GT; Lee JH; Cho ML; Kim SI
Immunol Lett; 2011 Oct; 140(1-2):97-103. PubMed ID: 21798287
[TBL] [Abstract][Full Text] [Related]
36. Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.
Bai F; Tian H; Niu Z; Liu M; Ren G; Yu Y; Sun T; Li S; Li D
Int J Mol Med; 2014 Mar; 33(3):711-21. PubMed ID: 24378614
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterisation of CR6086, a potent prostaglandin E
Caselli G; Bonazzi A; Lanza M; Ferrari F; Maggioni D; Ferioli C; Giambelli R; Comi E; Zerbi S; Perrella M; Letari O; Di Luccio E; Colovic M; Persiani S; Zanelli T; Mennuni L; Piepoli T; Rovati LC
Arthritis Res Ther; 2018 Mar; 20(1):39. PubMed ID: 29490676
[TBL] [Abstract][Full Text] [Related]
38. T-614 alters the production of matrix metalloproteinases (MMP-1 andMMP-3) and inhibits the migratory expansion of rheumatoid synovial fibroblasts, in vitro.
Du F; Lü LJ; Teng JL; Shen N; Ye P; Bao CD
Int Immunopharmacol; 2012 May; 13(1):54-60. PubMed ID: 22446297
[TBL] [Abstract][Full Text] [Related]
39. Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms.
Thiel MJ; Schaefer CJ; Lesch ME; Mobley JL; Dudley DT; Tecle H; Barrett SD; Schrier DJ; Flory CM
Arthritis Rheum; 2007 Oct; 56(10):3347-57. PubMed ID: 17907188
[TBL] [Abstract][Full Text] [Related]
40. Kinsenoside inhibits the inflammatory mediator release in a type-II collagen induced arthritis mouse model by regulating the T cells responses.
Hsiao HB; Hsieh CC; Wu JB; Lin H; Lin WC
BMC Complement Altern Med; 2016 Feb; 16():80. PubMed ID: 26916550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
